Total Funding
59
44
Total FundingNon-equity Assistance raised
Growth Score
-4 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
120692
Novel paradigm-shifting vaccines with emphasis on cellular immunity
- Andreas Regnery: Co-CEO
- Oliver Reimann: Co-founder, Co-CEO
About the Company
Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity.
